Metall ZugLTS:0QLX +0.28%63 PS Ratio is 2.97 as of Jul. 07, 2026, which is 165% above its 10-year median of 1.12. GuruFocus rates LTS:0QLX with a GF Score™ of 63/100 and a GF Value™ of CHF784.27 (Fairly Valued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Metall Zug ranks worse than 50.68% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Metall Zug's share price is CHF729.00.
Metall Zug's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF245.56. Hence, Metall Zug's PS Ratio for today is 2.97.
The historical rank and industry rank for Metall Zug's PS Ratio or its related term are showing as below:
LTS:0QLX'
s PS Ratio Range Over the Past 10 Years
Min: 0.36 Med: 1.12 Max: 2.98
Current: 2.98
During the past 13 years, Metall Zug's highest PS Ratio was 2.98. The lowest was 0.36. And the median was 1.12.
LTS:0QLX's PS Ratio is ranked worse than 50.68% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs LTS:0QLX: 2.98
Metall Zug Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Metall Zug was -31.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -33.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -24.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -13.80% per year.
During the past 13 years, Metall Zug's highest 3-Year average Revenue per Share Growth Rate was 14.20% per year. The lowest was -33.00% per year. And the median was 2.20% per year.
Back to Basics: PS Ratio
Metall Zug (LTS:0QLX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Metall Zug PS Ratio Related Terms
Metall Zug PS Ratio Historical Data
* Premium members only.
The historical data trend for Metall Zug's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Metall Zug's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metall Zug PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Metall Zug's PS Ratio distribution charts can be found below:
* The bar in red indicates where Metall Zug's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Metall Zug's Share Price of today is CHF729.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metall Zug's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF245.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Metall Zug (LTS:0QLX) has a PS Ratio of 2.97 as of Jul. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Metall Zug and its competitors. This is 165% above median its historical median of 1.12. Over the past decade, Metall Zug's PS Ratio has ranged from 0.36 to 2.98. According to the industry distribution chart, Metall Zug ranks #408 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 50.7%.
Is Metall Zug's PS Ratio too high?
Metall Zug's current PS Ratio of 2.97 is 165% above median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 2.98. The Medical Devices & Instruments industry median PS Ratio is 2.94. Metall Zug's value of 2.97 is 1% above this industry median. Based on the distribution chart, Metall Zug ranks #408 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Metall Zug has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metall Zug's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Metall Zug ranks #408 out of 805 companies for PS Ratio. This places Metall Zug in the lower half of its industry. The industry median PS Ratio is 2.94. Metall Zug's value of 2.97 is 1% above this benchmark. Historically, Metall Zug's own PS Ratio has ranged from 0.36 to 2.98 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 2.94, Metall Zug has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metall Zug's current PS Ratio of 2.97 is 1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Metall Zug and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metall Zug's current PS Ratio is 2.97, which is 165% above median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metall Zug stock overvalued right now?
Based on GuruFocus' analysis, Metall Zug (LTS:0QLX) is currently considered Fairly Valued. The stock's GF Value™ is CHF784.27, compared to a current price of CHF729.00 — trading 7% below its estimated fair value. The current PS Ratio is 2.97, which is 165% above median its 10-year median of 1.12 and 1% above the Medical Devices & Instruments industry median of 2.94. Metall Zug's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Metall Zug (LTS:0QLX), the current PS Ratio is 2.97 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metall Zug (LTS:0QLX) Overvalued in 2026?
Based on GuruFocus' analysis, Metall Zug stock appears to be undervalued.
The current stock price of CHF729.00 is trading 7% below its estimated GF Value™ of CHF784.27.
GuruFocus considers Metall Zug to be Fairly Valued.
Key valuation signals for LTS:0QLX:
PS Ratio: 2.97 (165% above median its 10-year median of 1.12)
GF Value™: CHF784.27 vs. price of CHF729.00 (7% below fair value)
Industry Position: 1% above the Medical Devices & Instruments median (#408 of 805)
No single metric tells the full story. See the LTS:0QLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
63GF Score
Get the complete analysis for LTS:0QLX
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLX has been successfully added to your 
